AXQ Capital’s Halozyme HALO Stock Holding History

AXQ Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.13M	Sell	19,280 -11,551	-37%	-$1.12M	0.28%	96
2026 Q2	$2.41M	Buy	30,831 +16,277	+112%	+$1.11M	0.26%	108
2026 Q1	$941K	Buy	+14,554	New	+$1.03M	0.12%	253
2025 Q3	–	Sell	-7,392	Closed	-$385K	–	686
2025 Q2	$385K	Buy	+7,392	New	+$421K	0.12%	288
2023 Q1	–	Sell	-8,531	Closed	-$485K	–	544
2022 Q4	$485K	Buy	+8,531	New	+$437K	0.34%	99

Other funds holding HALO

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

AXQ Capital's HALO Position: Q3 2026 in Review

AXQ Capital reduced its Halozyme (HALO) stake by 37% in Q3 2026, selling an estimated $1.12M and leaving 19,280 shares worth $2.13M. The position accounts for 0.28% of the portfolio, ranked #96.

AXQ Capital first reported a position in HALO in Q4 2022 and has held it in 5 quarters since. The position peaked at $2.41M in Q2 2026. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

AXQ Capital held 19,280 shares of Halozyme worth $2.13M as of Q3 2026.
AXQ Capital sold 11,551 Halozyme shares in Q3 2026, an estimated $1.12M.
Halozyme made up 0.28% of AXQ Capital's portfolio in Q3 2026, its #96 holding.
AXQ Capital first reported a position in Halozyme in Q4 2022 and has held it in 5 quarters since.
AXQ Capital's Halozyme position peaked at $2.41M in Q2 2026.
636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.